dihexa long-term safety Dihexa: Mechanism, Effects & Research Studies Dihexa Peptide Therapy: Brain &

Certain therapies discussed may be investigational and are not approved by the FDA for the diagnosis, treatment, cure, or prevention of disease

Studies suggest that BPC-157s NO modulation and vascular stabilization may complement TB-500s pro-migration of endothelial progenitors or microvascular sprouting dynamics

Peptide therapy can help address the root cause of this imbalance

The putative endothelium-derived relaxing factor, S-nitroso-L-cysteine, a stab1e deaminated analog of S-nitroso-L-cysteine, S-nitroso-3-mercaptoproprionic acid and sodium nitroprusside produced concentration-dependent (1-100 uM) increase (1.5- to 12-fold) in rabbit pulmonary arterial smooth muscle cells cyclic guanosine monophospate levels

Regulatory Simplicity: As a dietary supplement, oral BPC-157 does not require prescriptions, medical consultations, or relationships with compounding pharmacies that characterize many injectable peptide protocols